Öcal, Osman
Peynircioglu, Bora
Loewe, Christian
van Delden, Otto
Vandecaveye, Vincent
Gebauer, Bernhard
Zech, Christoph J.
Sengel, Christian
Bargellini, Irene
Iezzi, Roberto
Benito, Alberto
Schütte, Kerstin
Gasbarrini, Antonio
Seidensticker, Ricarda
Wildgruber, Moritz
Pech, Maciej
Malfertheiner, Peter
Ricke, Jens
Seidensticker, Max
Funding for this research was provided by:
Bayer HealthCare
Sirtex
Article History
Received: 14 April 2021
Revised: 1 July 2021
Accepted: 15 July 2021
First Online: 31 August 2021
Declarations
:
: The scientific guarantor of this publication is Max Seidensticker.
: Bernhard Gebauer: Personal fees: Bayer, Sirtex.Irene Bargellini: Grants: Sirtex, during the conduct of the study. Personal fees: Bayer, Sirtex, Biocompatibles, Terumo, outside the submitted work.Maciej Pech: Grants: Sirtex, Bayer; Personal fees: Sirtex.Peter Malfertheiner: Grants: Bayer, Sirtex.Jens Ricke: Grants: Sirtex, Bayer; Personal fees: Sirtex, Bayer.Max Seidensticker: Personal fees: Bayer, Sirtex
: One of the authors (OÖ) has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: The main results of the clinical trial have been previously reported in <i>Ricke J Hepatology 2019.</i>
: • retrospective• diagnostic or prognostic study• multicenter study